SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently experiencing extreme volatility and massive investor attention following its IPO, with retail traders aggressively piling into the stock despite significant skepticism regarding its fundamental valuation. Community discourse is sharply divided between believers in a multi-trillion-dollar space economy and critics warning of a speculative bubble, as traders closely monitor insider lockup expirations and the introduction of options trading.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant market debate as investors weigh its role as a foundational AI infrastructure provider against its high valuation and recent price volatility. The community is actively discussing the stock's consolidation near key technical support levels, with many traders speculating on whether it serves as a long-term 'buy-the-dip' opportunity or remains vulnerable to further downside amid shifting sector momentum.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing high volatility as investors weigh strong enterprise demand and a massive user base against aggressive insider selling and intense short interest. The community remains deeply divided, with bulls pointing to the company's sticky workflow integrations and strong growth, while bears express concern over its persistent unprofitability and intense competition from AI-native design tools.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors weigh persistent inflationary pressures against potential volatility in the tech sector, leading to active community debate regarding the durability of the AI-driven market rally. Traders are closely monitoring the interplay between geopolitical developments and macroeconomic data, utilizing inverse ETFs like SQQQ to hedge against a possible pullback from recent highs.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as investors aggressively rotate capital into tech and AI-related growth stocks, fueled by strong corporate earnings and continued market optimism. Community sentiment remains polarized, with many traders actively debating the sustainability of the current rally versus the risks of leveraged decay and potential geopolitical instability.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is surging alongside the broader memory and storage sector as investors respond to analyst price target increases and sustained, structural demand for data center and AI-related storage infrastructure. The community is actively discussing the stock's role in the ongoing memory cycle, with widespread debate over whether this represents a long-term re-rating or a temporary bubble fueled by intense sector momentum.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor focus due to a combination of institutional accumulation and strong fundamental growth, even as share price action remains volatile. Community members are actively debating the company's valuation gap compared to its consistent profitability, while closely monitoring geopolitical developments and interest rate environments as potential catalysts for a rebound.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is currently in the spotlight as traders closely watch its price action following technical signals indicating a potential correction or reversal after recent bounces. Community sentiment remains mixed, with active discussions focused on regulatory updates, broader market volatility, and speculation surrounding its potential for long-term recovery.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is under pressure following a dilutive stock offering priced at $10.75 per share, sparking frustration among retail investors over the timing and pricing of the capital raise. Despite the immediate negative reaction, the community remains divided, with long-term investors pointing to the company's de-risked clinical pipeline and significant cash runway into 2028 as reasons to maintain a bullish outlook.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is facing significant downward pressure and intense retail frustration as investors grapple with ongoing geopolitical tensions, regulatory scrutiny over e-commerce practices, and persistent underperformance compared to U.S. tech stocks. While some community members continue to view the stock as an undervalued AI play worth accumulating on dips, many are actively debating whether it remains a structural value trap or a long-term turnaround opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MGTX Stunned to hear Zandy say this today as a way of explaining how Meira was able to buy back the Botavec asset:  &quot;J&amp;J shut down their eye programs end of 2024.&quot; (and we bought it back).  I had not heard this before and now it makes more sense why J&amp;J took so long to make a decision on filing.  But what an entry for Lilly who is looking to build out their Opthalmology footprint- I could definitely see &quot;Meira Ocular&quot; being sold to Lilly in the future (there&#39;s so much more to $MGTX than ocular)

Mike Long

waterlock

Ernest Worthing

Meira

StockTwits Web

MeiraGTx Holdings plc

 Stunned to hear Zandy say this today as a way of explaining how Meira was able to buy back the Botavec asset:  "J&J shut down their eye programs end of 2024." (and we bought it back).  I had not heard this before and now it makes more sense why J&J took so long to make a decision on filing.  But what an entry for Lilly who is looking to build out their Opthalmology footprint- I could definitely see "Meira Ocular" being sold to Lilly in the future (there's so much more to 

Mak De

@Helpmrwizard I’m still having a hard to verifying that claim broadly. It’s somewhat supported by jnj employees joining mgtx but I don’t see anywhere jnj said that.

StockTwits for iOS

 I’m still having a hard to verifying that claim broadly. It’s somewhat supported by jnj employees joining mgtx but I don’t see anywhere jnj said that.

Aim Small

@Helpmrwizard If Lilly believes in Riboswitch, then they buy the company to improve GLp-1 and the optionality.  Ocular is just so they can see under the hood.

 If Lilly believes in Riboswitch, then they buy the company to improve GLp-1 and the optionality.  Ocular is just so they can see under the hood.